Publication | Closed Access
Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C.
139
Citations
0
References
2004
Year
These cases suggest that infliximab therapy may be safe in some quiescent or controlled chronic HBV or HCV infection.